Karyotypic Aberrations in Oncogenesis and Cancer Therapy

Ilio Vitale; Gwenola Manic; Laura Senovilla; Guido Guido Kroemer; Lorenzo Galluzzi

doi:10.1016/j.trecan.2015.08.001

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2013

Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy

Laura Senovilla, Lorenzo Galluzzi, Maria Castedo, Guido Guido Kroemer

Article2021

Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer

Kadi Lõhmussaar, Rurika Oka, Jose Espejo Valle-Inclán, Milou H.H. Smits, Hila Wardak, Jeroen Korving, Harry Begthel, Natalie Proost, Marieke van de Ven, Onno Kranenburg, Trudy Jonges, Ronald P. Zweemer, Sebastiaan Veersema, Ruben van Boxtel, Hans Clevers

Chapter in a book1986

Oncogenesis in Transgenic Mice

Douglas Hanahan

Article2009

Inflammation and oncogenesis: a vicious connection

Sergei I. Grivennikov, Michael Karin

Article2001

K-<i>ras</i> and <i>p16</i> Aberrations Confer Poor Prognosis in Human Colorectal Cancer

Manel Esteller, Sara González, Rosa Ana Risques, E. Marcuello, Ramón Mangues, Josep R. Germà, James G. Herman, Gabriel Capellà, Miguel A. Peinado